Clinical

An upsurge in cases of monkeypox earlier this year displaced mainstream media coverage of COVID-19—for a while, anyway. Now that new cases have slowed, that attention has shifted back to concerns for a resurgence of the pandemic and an accompanying increase in other respiratory viruses. Urgent care providers should be aware that certain complications of monkeypox linger, though, as noted in an article just published by JAMA Neurology. Such vigilance could actually aid in retrospective …

Urgent care as an industry has made a firm commitment to reducing inappropriate prescriptions for antibiotics. Most often, we picture a clinician resisting patient demands for a script even though they’re experiencing a viral respiratory infection or fighting the urge to write one just in case a culture comes back positive. According to a Medpage Today article based on data presented at IDWeek, a group of hospitals in Michigan found that taking a step back …

With this flu season expected to be harsher than others in recent years, while respiratory syncytial virus and COVID-19 are also circulating widely, it will be especially important to ensure that as many Americans as possible are suitably vaccinated. Unfortunately, as was made clearer than ever during the height of the pandemic, some racial and ethnic groups are at greater risk for illness and poor outcomes during viral outbreaks. In fact, according to a new …

Just last week, we told you that unusually high cases of respiratory syncytial virus, added to existing concerns over COVID-19 and influenza season, have public health officials in the United States worrying about simultaneous epidemic-level surges of all three viruses. Already, data are pouring in from around the country, raising the alarm that what was first thought to be a potential near-future problem may be an actual present-day crisis. An article published in the Virginia …

High demand, supply-chain challenges, and difficulties sourcing raw materials are combining to leave the United States with an insufficient supply of amoxicillin. According to an article published by Bloomberg, Hikma Pharmaceuticals, Teva Pharmaceuticals Industries, and Sandoz are experiencing shortages of multiple dosage forms of the antibiotic (though the greatest deficit is with the liquid form). The net effect is that new orders are being limited to ensure current demand can be met for as long …

Mainstream and healthcare media (including JUCM and JUCM News) have been warning for weeks that the United States could be teed up for a twindemic—simultaneous epidemic-level cases of both COVID-19 and influenza—this year. As it turns out, that could be a less-than-worst-case scenario this winter. A report published by The New York Times says it would be prudent to throw respiratory syncytial virus into the mix of things to worry about in the coming months; …

As JUCM News readers know, infectious disease and public health experts have been saying for weeks that we could see a severe flu season this year, especially compared to the last few when people wore masks and practiced social distancing due to COVID-19. Data are already proving them out, and the fact that they’re emerging so early in the season is raising red flags. Not only that, but some of the states with the highest …

The Centers for Disease Control and Prevention has issued an Official Health Advisory to urge U.S. clinicians to include Ebola virus disease (EVD) in their differential diagnoses for patients presenting with fever, headache, muscle and joint pain, fatigue, loss of appetite, gastrointestinal symptoms, and unexplained bleeding. The advisory also recommends taking a detailed travel history for such patients. There is an active outbreak occurring within five districts in Uganda, but at present there have been …

Though ivermectin has been the most widely discussed medication purported to help fight or prevent COVID-19, metformin and fluvoxamine have also been put forth by some as candidates to draw the pandemic to a quick close. And each of them has proven to be highly effective within their approved indications. The problem is that none has been helpful in fighting SARS-CoV-2, according to research published by The New England Journal of Medicine. After randomly assigning …

As JUCM readers know, public health officials have expressed concern that the much dreaded—but previously unrealized—simultaneous spike in influenza and SARS-CoV-2 could overwhelm the U.S. healthcare system, kill unknown masses of patients, and pummel the nation’s economy. Unfortunately, fresh insights gleaned from the start of the U.S. flu season are doing nothing assuage those fears. In fact, Vanderbilt infectious disease professor and highly regarded public health expert William Schaffner, MD told NPR just last week, …